ORPH

Q: What is the price of Orphazyme (ORPH) today?

A cotação de Orphazyme (ORPH) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. negociando na casa dos $ 0.00 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.

Q: When does Orphazyme (ORPH) pay dividends?

Orphazyme (ORPH) did not pay dividends over the past year.

Q: Is Orphazyme (ORPH) a good investment?

Atualmente, Orphazyme (ORPH) está cotada a $ 0.00, com um P/L de 0.00, This represents a 0% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Orphazyme A/S

Price

$ -

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ORPH price

ORPH

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ORPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ORPH

review the fundamentals of Orphazyme shares

P/E

0.00

Sector: -4.09 Industry: -4.09

P/S (PSR)

Sector: -3.87 Industry: -3.87

P/BV

0.00

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.00%

Sector: -61.28% Industry: -61.28%

ROE

0.00%

Sector: -61.00% Industry: -61.00%

ROIC

Sector: -2,142.55% Industry: -2,142.55%

NET MARGIN

0.00%

Sector: -39.07% Industry: -39.07%

GROSS MARGIN

0.00%

Sector: 37.83% Industry: 37.83%

OPERATING MARGIN

0.00%

Sector: -39.17% Industry: -39.17%

EV/EBITDA

Sector: -3.91 Industry: -3.91

EV/EBIT

Sector: -4.18 Industry: -4.18

PRICE-TO-ASSETS

Sector: 1.39 Industry: 1.39

BVPS

Sector: 1.88 Industry: 1.88

EPS

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals ORPH

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.01	6.74	25.92%	2.29%	$ 547.30 B	21.83%
PFE	19.27	1.61	8.35%	6.53%	$ 149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$ 365.48 B	5.79%
NVO	12.44	6.41	51.50%	4.25%	$ 194.87 B	33.05%
MRK	31.01	0.00	0.00%	2.96%	$ 277.04 B	13.59%
AZN	27.54	6.04	21.93%	1.73%	$ 286.16 B	17.19%
GILD	19.21	7.23	37.62%	2.42%	$ 163.51 B	28.90%
BMY	16.31	0.00	0.00%	4.29%	$ 118.65 B	15.01%
ZTS	18.71	15.01	80.25%	1.78%	$ 50.00 B	28.23%
REGN	16.49	2.32	14.08%	0.51%	$ 72.95 B	29.65%
HALO	23.82	154.63	649.21%	0.00%	$ 7.55 B	22.69%
AMGN	22.83	19.38	84.87%	2.93%	$ 178.10 B	20.96%
MCK	23.07	-1,011.36	-4,383.84%	0.39%	$ 100.12 B	1.09%
VRTX	27.24	5.77	21.18%	0.00%	$ 107.68 B	32.94%
HRMY	11.43	2.08	18.24%	0.00%	$ 1.81 B	18.27%
CAH	29.51	-17.17	-58.20%	1.05%	$ 45.88 B	0.62%
ADMA	17.04	5.25	30.78%	0.00%	$ 2.50 B	28.80%
BIIB	20.04	1.47	7.36%	0.00%	$ 27.50 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

ORPH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Orphazyme

Orphazyme A/S

Average Investor10 user rating

4.0 (0 people)

United States

17 years

Founded: 2009

2020

Time since IPO - 6 years

141

Employees

Orphazyme A/S (United States) is listed on the Nasdaq and has a market capitalization of $11.81 Millions, with shareholders equity totaling $-.

The company employs approximately 141 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Orphazyme A/S reported $- in revenue, generating net income of $-.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ORPH.

Market cap

$ 11.81 Millions

Net worth

$ -

Assets

$ -

Total Shares Outstanding

34.95 Millions

34,952,000

Average Daily Trading Volume

$ -

Sector

Health Care

Industry

Biotechnology

ORPH

ORPH revenue and profits

Financial Results ORPH

DRAG THE FRAME TO SEE MORE DATA

ORPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 754.76 9,89% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$ 185.28 27,23% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$ 222.51 47,80% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$ 26.48 25,70% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$ 112.30 49,88% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 182.52 37,47% (12M)

P/E

27.54

1.73%

ROE

21.93%

P/BV

6.04

ABBV - AbbVie

$ 202.71 13,74% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 754.76 9,89% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$ 185.28 27,23% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$ 222.51 47,80% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$ 26.48 25,70% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$ 112.30 49,88% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 182.52 37,47% (12 M)

P/L

27.54

1.73%

ROE

21.93%

P/VP

6.04

ABBV - AbbVie

$ 202.71 13,74% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

Frequently Asked Questions

What is the price of Orphazyme (ORPH) today?

A cotação de Orphazyme (ORPH) hoje está em $ 0.00, com uma variação de The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. negociando na casa dos $ 0.00 e hoje está em $ 0.00. Acompanhe o and track broader market trends directly on the platform.

When does Orphazyme (ORPH) pay dividends?

Orphazyme (ORPH) did not pay dividends over the past year.

Is Orphazyme (ORPH) a good investment?

Atualmente, Orphazyme (ORPH) está cotada a $ 0.00, com um P/L de 0.00, This represents a 0% premium compared to its historical average P/E. uma variação de 0 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Orphazyme (ORPH) stock?

You can buy Orphazyme (ORPH) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ORPH and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Orphazyme (ORPH) yield today?

Over the past month, Orphazyme (ORPH) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Orphazyme (ORPH) hoje, o investimento total seria de $ 0.00, com base na cotação atual de $ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: $ 0.00
Em 5 anos: $ 0.00
Em 10 anos: $ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ORPH

Orphazyme A/S

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ORPH

review the fundamentals of Orphazyme shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Orphazyme

Orphazyme A/S

United States

17 years

2020

141

Financial Results ORPH

ORPH cash flow

Asset, Revenue and Profit Growth - ORPH

ORPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

Frequently Asked Questions